Signaturefd, LLC Abb Vie Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 46,694 shares of ABBV stock, worth $8.18 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

46,694

Previous 48,837 4.39%

Holding current value

$8.18 Million

Previous $8.38 Million 10.09%

% of portfolio

0.18%

Previous 0.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$163.84 - $199.33 $351,109 - $427,164	-2,143 Reduced 4.39%	46,694 $9.22 Million
Q2 2024 Jul 29, 2024	BUY	$154.79 - $180.76 $97,208 - $113,517	628 Added 1.3%	48,837 $8.38 Million
Q1 2024 May 03, 2024	BUY	$159.82 - $182.1 $414,253 - $472,003	2,592 Added 5.68%	48,209 $8.78 Million
Q4 2023 Jan 31, 2024	SELL	$137.6 - $154.97 $187,824 - $211,534	-1,365 Reduced 2.91%	45,617 $7.07 Million
Q3 2023 Nov 03, 2023	BUY	$133.59 - $154.65 $434,969 - $503,540	3,256 Added 7.45%	46,982 $7 Million
Q2 2023 Aug 01, 2023	SELL	$132.51 - $164.9 $482,071 - $599,906	-3,638 Reduced 7.68%	43,726 $5.89 Million
Q1 2023 Apr 28, 2023	BUY	$144.61 - $166.54 $595,793 - $686,144	4,120 Added 9.53%	47,364 $7.55 Million
Q4 2022 Jan 27, 2023	BUY	$138.31 - $165.87 $194,740 - $233,544	1,408 Added 3.37%	43,244 $6.99 Million
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $290,698 - $333,412	2,166 Added 5.46%	41,836 $5.62 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $47,616 - $60,536	-346 Reduced 0.86%	39,670 $6.08 Million
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $537,818 - $667,281	4,075 Added 11.34%	40,016 $6.49 Million
Q4 2021 Jan 25, 2022	BUY	$107.43 - $135.93 $450,453 - $569,954	4,193 Added 13.21%	35,941 $4.87 Million
Q3 2021 Oct 28, 2021	SELL	$106.4 - $120.78 $33,728 - $38,287	-317 Reduced 0.99%	31,748 $3.43 Million
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $268,180 - $298,768	2,549 Added 8.64%	32,065 $3.61 Million
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $187,822 - $206,770	1,836 Added 6.63%	29,516 $3.19 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $2.23 Million - $3.01 Million	27,680 New	27,680 $2.97 Million
Q3 2020 Nov 03, 2020	SELL	$85.91 - $100.83 $2.12 Million - $2.49 Million	-24,690 Closed	0 $0
Q2 2020 Jul 30, 2020	BUY	$73.37 - $98.18 $4,108 - $5,498	56 Added 0.23%	24,690 $2.42 Million
Q1 2020 Apr 23, 2020	SELL	$64.5 - $97.79 $407,962 - $618,521	-6,325 Reduced 20.43%	24,634 $1.88 Million
Q4 2019 Feb 05, 2020	BUY	$72.13 - $90.25 $1.11 Million - $1.39 Million	15,406 Added 99.05%	30,959 $2.74 Million
Q3 2019 Oct 16, 2019	SELL	$62.98 - $75.72 $68,018 - $81,777	-1,080 Reduced 6.49%	15,553 $1.18 Million
Q2 2019 Jul 31, 2019	BUY	$65.7 - $83.98 $166,418 - $212,721	2,533 Added 17.96%	16,633 $1.21 Million
Q1 2019 May 09, 2019	SELL	$77.14 - $90.79 $73,514 - $86,522	-953 Reduced 6.33%	14,100 $1.14 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $108,445 - $133,741	1,393 Added 10.2%	15,053 $1.39 Million
Q3 2018 Nov 15, 2018	SELL	$88.91 - $98.84 $563,778 - $626,744	-6,341 Reduced 31.7%	13,660 $1.29 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $1,346 - $1,593	15 Added 0.08%	20,001 $1.85 Million
Q1 2018 May 08, 2018	BUY	$92.01 - $123.21 $817,232 - $1.09 Million	8,882 Added 79.99%	19,986 $1.89 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $144,908 - $158,903	1,618 Added 17.06%	11,104 $1.07 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $2,095 - $2,676	30 Added 0.32%	9,486 $843,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,456	9,456 $686,000

Others Institutions Holding ABBV

# of Institutions

3,855

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account